US Stock MarketDetailed Quotes

AVDX AvidXchange

Watchlist
  • 7.600
  • +0.240+3.26%
Close Feb 28 16:00 ET
  • 7.600
  • 0.0000.00%
Post 16:30 ET
1.55BMarket Cap190.00P/E (TTM)

AvidXchange Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

AvidXchange Q4 2024 Earnings Date

Currency：USDFeb 26, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
114.75M
115.44M
+686.97K
Beat Est.
+10.27%
+10.93%
+0.60%
EPS
0.01
0.02
+<0.01
Beat Est.
+161.81%
+200.00%
+62.60%
Analyst Rating
Hold

Mar 1, 2025

AvidXchange Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 14 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 111.233M--
--2025/Q1-- / 109.732M--
Feb 26, 20252024/Q4115.438M / 114.751M--
Nov 6, 20242024/Q3112.772M / 110.825M--
Jul 31, 20242024/Q2105.132M / 106.877M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 111.233M--
--2025/Q1-- / 109.732M--
Feb 26, 20252024/Q4115.438M / 114.751M--
Nov 6, 20242024/Q3112.772M / 110.825M--
Jul 31, 20242024/Q2105.132M / 106.877M--

Unlock Free Earnings Estimates

AvidXchange Earnings Reports

  • AvidXchange | 10-K: FY2024 Annual Report

    Feb 28 16:02 ET

  • AvidXchange | 8-K: AvidXchange Announces Fourth-Quarter & Full-Year 2024 Financial Results

    Feb 26 06:51 ET

  • AvidXchange | 10-Q: Q3 2024 Earnings Report

    Nov 8, 2024 16:10 ET

  • AvidXchange | 8-K: AvidXchange Announces Third Quarter 2024 Financial Results

    Nov 6, 2024 06:52 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Cars.com
    CARS
    +9.73%
    Lantheus
    LNTH
    +2.55%
    Halozyme Therapeutics
    HALO
    +2.51%
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +2.27%
    Collegium Pharmaceutical
    COLL
    +2.22%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Mar 1, 2025

    Hold

    • Buy

      33.33%

    • Hold

      53.33%

    • Sell

      13.33%

    Price Target

    No Data